Child and parent perspectives of the chronic graft-versus-host disease (cGVHD) symptom experience: a concept elicitation study
- 270 Downloads
- 7 Citations
Abstract
Purpose
Chronic graft-versus-host disease (cGVHD) is a significant cause of mortality and morbidity after allogeneic hematopoietic cell transplant and is associated with a wide range of distressing symptoms. A pediatric measure of cGVHD-related symptoms is needed to advance clinical research. Our aim was to elicit descriptions of the cGVHD symptom experience directly from children and to compare the specific language used by children to describe their symptoms and the comprehension of symptom concepts across the developmental spectrum.
Methods
We used qualitative methods to identify the phrases, terms, and constructs that children (ages 5–8 [n = 8], 9–12 [n = 8], and 13–17 [n = 8]) with cGVHD employ when describing their symptoms. The symptom experience of each participant was determined through individual interviews with each participant and parent (5–7 year olds were interviewed together with a parent). Medical practitioners with experience in evaluating cGVHD performed clinical assessments of each participant.
Results
Pediatric transplant survivors and their parents identified a wide range of bothersome cGVHD symptoms, and common concepts and terminologies to describe these experiences emerged. Overall concordance between patient and parent reports was moderate (70–75 %). No consistent pattern of child under- or over-reporting in comparison to the parent report was observed.
Conclusion
These study results identify concepts and vocabulary to inform item generation for a new pediatric self-report measure of cGVHD symptoms for use in clinical research. The findings also confirm the prevalence and nature of symptom distress in pediatric patients with cGVHD and support implementation of systematic approaches to symptom assessment and intervention in routine clinical practice.
Keywords
Chronic graft-versus-host disease Stem cell transplant Pediatric Symptom scale Patient-reported outcomes (PROs) QualitativeNotes
Acknowledgments
The authors would like to acknowledge the support of several individuals who helped make this work possible. We thank Lauren Latella, BS, Nia Billings, MA, and Sima Zadeh, MA who helped with the coding of the data and Stephanie Lee, MD who gave significant input and advice in developing this protocol. We thank Colleen Schaefer, BS, CRC and Meredith Marshall, MA, CRC who performed a number of the interviews and Haven Battles, PhD who calculated the Intra-class Correlation Coefficients. We especially thank the patients and their parents who so openly shared their experiences of living with chronic GVHD and how these symptoms impact their lives.
Conflict of interest
The authors have no conflict of interest to report. The authors have full control of all primary data and agree to allow the journal to review our data, if requested.
References
- 1.Jacobsohn DA, Arora M, Klein JP et al (2011) Risk factors associated with increased nonrelapse mortality and with poor overall survival in children with chronic graft-versus-host disease. Blood 118(16):4472–4479PubMedCrossRefGoogle Scholar
- 2.Vogelsang GB, Wagner JE (1990) Graft-versus-host disease. Hematol Oncol Clin North Am 4:625–639PubMedGoogle Scholar
- 3.Ferrara JL, Deeg HJ (1991) Graft-versus-host disease. N Engl J Med 324:667–674PubMedCrossRefGoogle Scholar
- 4.Zecca M, Prete A, Rondelli R et al (2002) Chronic graft-versus-host disease in children: incidence, risk factors, and impact on outcome. Blood 100:1192–1200PubMedCrossRefGoogle Scholar
- 5.Shulman HM, Sullivan KM, Weiden PL et al (1980) Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 69:204–217PubMedCrossRefGoogle Scholar
- 6.Sullivan KM, Shulman HM, Storb R et al (1981) Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood 57:267–276PubMedGoogle Scholar
- 7.Filipovich AH, Weisdorf D, Pavletic S et al (2005) National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transpl 11(12):945–956CrossRefGoogle Scholar
- 8.Pavletic SZ, Martin P, Lee SJ et al (2006) Measuring therapeutic response in chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. Response criteria working group report. Biol Blood Marrow Transpl 12:252–266CrossRefGoogle Scholar
- 9.Jacobsohn DA, Kurland BF, Pidala J et al (2012) Correlation between NIH composite skin score, patient reported skin score and outcome: results from the chronic GVHD consortium. Blood 120(13):2545–2552PubMedCrossRefGoogle Scholar
- 10.Arai S, Jagasia M, Storer B et al (2011) Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria. Blood 118:4242–4249PubMedCrossRefGoogle Scholar
- 11.Drotor D (1998) Measuring health related quality of life in children and adolescents: implications for research and practice. Lawrence Erlbaum Associates, New JerseyGoogle Scholar
- 12.Varni JW, Sherman SA, Burwinkle TM, Dickinson PE, Dixon P (2004) The PedsQL family impact module: preliminary reliability and validity. Health Qual Life Outcomes 2:55PubMedCentralPubMedCrossRefGoogle Scholar
- 13.Bhatia S, Jenney ME, Bogue MK et al (2002) The Minneapolis–Manchester quality of life instrument: reliability and validity of the adolescent form. J Clin Oncol 20:4692–4698PubMedCrossRefGoogle Scholar
- 14.Bhatia S, Jenney ME, Wu E et al (2004) The Minneapolis–Manchester quality of life instrument: reliability and validity of the youth form. J Pediatr 145:39–46PubMedCrossRefGoogle Scholar
- 15.Parsons SK, Shih MC, Mayer DK et al (2005) Preliminary psychometric evaluation of the child health ratings inventory (CHRIs) and disease-specific impairment inventory-hematopoietic stem cell transplantation (DSII-HSCT) in parents and children. Qual Life Res 14:1613–1625PubMedCrossRefGoogle Scholar
- 16.Parsons SK, Shih MC, Duhamel KN et al (2006) Original research article: maternal perspectives on children’s health-related quality of life during the first year after pediatric hematopoietic stem cell transplant. J Pediatr Psychol 10:1100–1115Google Scholar
- 17.Lee S, Cook EF, Soiffer R, Antin JH (2002) Development and validation of a scale to measure symptoms of chronic graft-versus-host disease. Biol Blood Marrow Transpl 8:444–452CrossRefGoogle Scholar
- 18.Inamoto Y, Martin PJ, Chai X et al (2012) Clinical benefit of response in chronic graft-versus-host disease. Biol Blood Marrow Transpl 18(10):1517–1524CrossRefGoogle Scholar
- 19.Patrick DL, Burke LB, Gwaltney CJ et al (2011) Content validity-establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1-eliciting concepts for a New PRO instrument. Value in Health 14(8):967–977PubMedCrossRefGoogle Scholar
- 20.Matza LS, Patrick D, Riley AW, Alexander JJ, Rajmil L, Pleil AM, Bullinger M (2013) Pediatric patient-reported outcome instruments for research to support medical product labeling: report of the ISPOR PRO Good Research Practices for the Assessment of Children and Adolescents Task Force. Value Health 16:461–479PubMedCrossRefGoogle Scholar
- 21.DeMuro CJ, Lewis SA, DiBenedetti DB, Price MA, Fehnel SE (2012) Successful implementation of cognitive interviews in special populations. Expert Rev Pharmacoecon Outcomes Res 12(2):181–187PubMedCrossRefGoogle Scholar
- 22.Brod M, Tesler LE, Christensen TL (2009) Qualitative research and content validity: developing best practices based on science and experience. Qual Life Res 18:1263–1278PubMedCrossRefGoogle Scholar
- 23.Mays N, Pope C (2000) Qualitative research in health care: assessing quality in qualitative research. Br Med J 320(7226):50CrossRefGoogle Scholar
- 24.Guest G, Bunce A, Johnson L (2006) How many interviews are enough? An experiment with data saturation and variability. Field Method 18(1):59–82CrossRefGoogle Scholar
- 25.Xiao C, Polomano R, Bruner DW (2012) Comparison between patient-reported and clinician-observed symptoms in oncology. Cancer Nurs. PMID: 23047799Google Scholar
- 26.Mitchell SA, Leidy NK, Mooney KH et al (2010) Determinants of functional performance in long-term survivors of allogeneic hematopoietic stem cell transplantation with chronic graft-versus-host disease (cGVHD). Bone Marrow Transpl 45(4):762–769CrossRefGoogle Scholar
- 27.Varni JW, Burwinkle TM, Katz ER, Meeske K, Dickinson P (2002) The PedsQL in pediatric cancer: reliability and validity of the pediatric quality of life inventory generic core scales. Multidim Fatigue Scale Cancer Module Cancer 94:2090–2106Google Scholar
- 28.Cremeens J, Eiser C, Blades M (2006) Characteristics of health-related self-report measures for children aged three to eight years: a review of the literature. Qual Life Res 15:739–754PubMedCrossRefGoogle Scholar
- 29.Russell KMW, Hudson M, Long A, Phipps S (2006) Assessment of health-related quality of life in children with cancer: consistency and agreement between parent and child reports. Cancer 106:2267–2274PubMedCrossRefGoogle Scholar
- 30.FDA: Guidance for Industry: Patient-reported outcome measures: Use in medical product development to support labeling claims (2006) Center for Drug Evaluation and Research, Food and Drug Administration, MDGoogle Scholar